InSpan awarded patent for treating spinal stenosis and fusion in ASCs

InSpan, an interspinous-interlaminar fixation device, has been implanted in thousands of degenerative spine disease patients since its FDA clearance in 2010 and has now been granted a patent for its interspinous technique and instruments designed for treating spinal stenosis and fusion in ASCs.

The patent protects InSpan's unique approach to spinal fixation that allows for less invasive surgery with quicker recovery times and less blood loss in the ASC setting. 

In 2021, InSpan became the first interspinous-interlaminar plate fixation device granted the dual FDA approval for spinal fusion and spinal stenosis from T1-S1 in selected patients, according to a March 21 press release.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast